Lenalidomide in Relapsed or Refractory Mantle Cell LymphomaLenalidomide in Relapsed or Refractory Mantle Cell Lymphoma

Get up-to-speed on studies of lenalidomide in relapsed/refractory MCL and compare the results with those of other novel agents being used for relapsed/refractory MCL. Therapeutic Advances in Hematology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news